Risk of acute postoperative hypertension after topical photodynamic therapy for non-melanoma skin cancer

Photodermatology Photoimmunology and Photomedicine

Volumn 29, Issue 2, 2013, Pages 73-77

  Borroni, Riccardo G ^a   Carugno, Andrea ^b   Rivetti, Nicolò ^b   Arbustini, Eloisa ^a   Brazzelli, Valeria ^b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Adverse event; Arterial hypertension; Methyl aminolevulinate; Non melanoma skin cancer; Photodynamic therapy

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; ANTIHYPERTENSIVE AGENT;

ACTINIC KERATOSIS; ACUTE POSTOPERATIVE HYPERTENSION; ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BOWEN DISEASE; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; HYPERTENSIVE CRISIS; MALE; NON MELANOMA SKIN CANCER; PHOTODYNAMIC THERAPY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

AGE FACTORS; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; BLOOD PRESSURE; BOWEN'S DISEASE; CARCINOMA, BASAL CELL; FEMALE; HUMANS; HYPERTENSION; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; PAIN; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; RISK FACTORS; SKIN NEOPLASMS;

EID: 84874711795     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/phpp.12019     Document Type: Article

References (13)

1. Braathen LR, Szeimies RM, Basset-Seguin N etal. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007; 56: 125-143.
2. Morton C, McKenna KE, Rhodes LE. Guidelines for topical photodynamic therapy: update. Br J Dermatol 2008; 159: 1245-1266.
3. Christensen E, Warloe T, Kroon S etal. Guidelines for practical use of MAL-PDT in non-melanoma skin cancer. J Eur Acad Dermatol Venereol 2010; 24: 505-512.
4. Morton CA, Whitehurst C, Moseley H, McColl JH, Moore JV, Mackie RM. Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol 1996; 135: 766-771.
5. Ibbotson SH. Adverse effects of topical photodynamic therapy. Photodermatol Photoimmunol Photomed 2011; 27: 116-130.
6. Gholam P, Denk K, Sehr T, Enk A, Hartmann M. Factors influencing pain intensity during topical photodynamic therapy of complete cosmetic units for actinic keratoses. J Am Acad Dermatol 2010; 63: 213-218.
7. Halldin CB, Gillstedt M, Paoli J, Wennberg AM, Gonzalez H. Predictors of pain associated with photodynamic therapy: a retrospective study of 658 treatments. Acta Derm Venereol 2011; 91: 545-551.
8. Fontes ML, Varon J. Perioperative hypertensive crisis: newer concepts. Int Anesthesiol Clin 2012; 50: 40-58.
9. Chobanian AV, Bakris GL, Black HR etal. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572.
10. Naldi L, Chatenoud L, Piccitto R etal. Prevalence of Actinic Keratoses Italian Study (PraKtis) Group. Prevalence of actinic keratoses and associated factors in a representative sample of the Italian adult population: results from the Prevalence of Actinic Keratoses Italian Study, 2003-2004. Arch Dermatol 2006; 142: 722-726.
11. White WB, Baker LH. Ambulatory blood pressure monitoring in patients with panic disorder. Arch Intern Med 1987; 147: 1973-1975.
12. Arits AH, van de Weert MM, Nelemans PJ, Kelleners-Smeets NW. Pain during topical photodynamic therapy: uncomfortable and unpredictable. J Eur Acad Dermatol Venereol 2010; 24: 1452-1457.
13. Wolf-Maier K, Cooper RS, Banegas JR etal. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 2003; 289: 2363-2369.